ProfileGDS5822 / ILMN_2838501
TitleAnti-CTLA-4 immunotherapy effect on αSMA+ myofibroblast late-depleted pancreatic ductal adenocarcinoma model
OrganismMus musculus


control myofibroblast depletion untreated anti-CTLA4 antibody GSM1276599 GSM1276600 GSM1276601 GSM1276602 GSM1276603 GSM1276604 GSM1303940 GSM1303941 GSM1303942 78% 72% 71% 77% 72% 68% 61% 67% 70% sort by protocol sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM1276599PDAC Late Ablation Control 1111.978
GSM1276600PDAC Late Ablation Control 265.772
GSM1276601PDAC Late Ablation Control 380.771
GSM1276602PDAC Late Ablation 196.577
GSM1276603PDAC Late Ablation 264.872
GSM1276604PDAC Late Ablation 352.168
GSM1303940PDAC Late Ablation_anti-CTLA4 129.461
GSM1303941PDAC Late Ablation_anti-CTLA4 255.167
GSM1303942PDAC Late Ablation_anti-CTLA4 371.170